Alto Neuroscience ANRO Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's other income (expense)?
- Alto Neuroscience (ANRO) reported other income (expense) of $901K in Q1 2026.
- How has Alto Neuroscience's other income (expense) changed year-over-year?
- Alto Neuroscience's other income (expense) increased by 77.7% year-over-year, from $507K to $901K.
- What is the long-term trend for Alto Neuroscience's other income (expense)?
- Over 2 years (2023 to 2025), Alto Neuroscience's other income (expense) has grown at a 44.2% compound annual growth rate (CAGR), from $1.5M to $3.13M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.